Seminars in Liver Disease

Papers
(The median citation count of Seminars in Liver Disease is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Critical Care Management of Acute-on-Chronic Liver Failure: Certainties and Unknowns76
Tight Junction Proteins as Therapeutic Targets to Treat Liver Fibrosis and Hepatocellular Carcinoma69
Liver Immunology, Immunotherapy, and Liver Cancers: Time for a Rethink?67
Hepatic Extracellular Matrix and Its Role in the Regulation of Liver Phenotype48
A Precision Medicine Guided Approach to the Utilization of Biomarkers in MASLD44
Patient-Reported Outcomes in Metabolic Dysfunction-Associated Steatotic Liver Disease40
HBV Biomarkers and Their Role in Guiding Treatment Decisions33
Genetic and Epigenetic Basis of Drug-Induced Liver Injury32
Tailored Model of Care for Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease31
Hepatic Alveolar Echinococcosis28
Genetic Contributions to Biliary Atresia: A Developmental Cholangiopathy28
Emerging Targets for the Treatment of Primary Sclerosing Cholangitis24
Finite Antiviral Therapy in Chronic Hepatitis B Patients with Cirrhosis24
Wilson Disease: Novel Diagnostic and Therapeutic Approaches23
Role of YAP1 Signaling in Biliary Development, Repair, and Disease22
Mechanisms of Pharmacoresistance in Hepatocellular Carcinoma: New Drugs but Old Problems21
Alcohol Plus Additional Risk Factors: Rodent Model of Liver Injury21
Growth Hormone Signaling in Liver Diseases: Therapeutic Potentials and Controversies20
Physiomimetic In Vitro Human Models for Viral Infection in the Liver19
Mice Engrafted with Human Liver Cells19
Dietary Recommendations for the Management of Non-alcoholic Fatty Liver Disease (NAFLD): A Nutritional Geometry Perspective18
Diagnosis and Management of Early Stages of ALD15
Current and Evolving Indications for Simultaneous Liver Kidney Transplantation15
Interleukin-17 in Liver Disease Pathogenesis14
Insights into Nonalcoholic Fatty-Liver Disease Heterogeneity14
Circadian Regulation of Gene Expression and Metabolism in the Liver13
A Global Systematic Review of Hepatitis C Elimination Efforts through Micro-Elimination13
Role of Complement in Liver Diseases13
12
To TIPS or Not to TIPS in High Risk of Variceal Rebleeding and Acute-on-Chronic Liver Failure11
Role of Intestinal Barrier Disruption to Acute-on-Chronic Liver Failure11
Liver Neurobiology: Regulation of Liver Functions by the Nervous System11
Primary Cilia in Hepatic Biliary Hyperplasia: Implications for Liver Diseases11
This Is What Metabolic Dysfunction–Associated Steatotic Liver Disease Looks Like: Potential of a Multiparametric MRI Protocol10
Erratum to: Drug-Induced Vanishing Bile Duct Syndrome: From Pathogenesis to Diagnosis and Therapeutics10
10
Mesenchymal Stem Cell Transplantation in Liver Diseases10
Liver Transplantation for Hepatocellular Carcinoma: A Narrative Review and A Glimpse into The Future10
Novel Biomarkers of AKI in Cirrhosis10
Management of Portal vein Thrombosis in Cirrhosis9
9
Hepatitis Delta Infection: A Clinical Review8
The Hepatic Porphyrias: Revealing the Complexities of a Rare Disease8
Hepatocellular Carcinoma Chemoprevention with Generic Agents8
Erratum to: Finite Antiviral Therapy in Chronic Hepatitis B Patients with Cirrhosis8
Artificial Intelligence in Hepatology: A Narrative Review8
Endoscopic Advances in Hepatology8
Erratum to: Genetic Contributions to Biliary Atresia: A Developmental Cholangiopathy8
Pediatric and Adult Liver Disease in Alpha-1 Antitrypsin Deficiency7
Advancements in MELD Score and Its Impact on Hepatology7
Is There a Safe Alcohol Consumption Limit for the General Population and in Patients with Liver Disease?7
LncRNAs, RNA Therapeutics, and Emerging Technologies in Liver Pathobiology7
The Mechanism of Interleukin-35 in Chronic Hepatitis B7
Research Progress on the Role and Mechanism of IL-37 in Liver Diseases7
Noninvasive Tests to Assess Fibrosis and Disease Severity in Metabolic Dysfunction-Associated Steatotic Liver Disease7
Toward a Liver Cell Atlas: Understanding Liver Biology in Health and Disease at Single-Cell Resolution7
Extracellular Vesicles and Micro-RNAs in Liver Disease7
Big Data Analytics in Large Cohorts: Opportunities and Challenges for Research in Hepatology6
Screening for At-Risk Nonalcoholic Fatty Liver Disease in the Primary Care Setting6
Metabolic Injury of Hepatocytes Promotes Progression of NAFLD and AALD6
Unraveling the Complexities of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma5
Hepatic Innervations and Nonalcoholic Fatty Liver Disease5
Nonalcoholic Fatty Liver Disease: Current Global Burden5
Erratum to: Scavenger Receptors: Novel Roles in the Pathogenesis of Liver Inflammation and Cancer5
Understanding Hepatic Porphyrias: Symptoms, Treatments, and Unmet Needs5
Scavenger Receptors: Novel Roles in the Pathogenesis of Liver Inflammation and Cancer5
Shared Mechanisms between Cardiovascular Disease and NAFLD5
Immune Checkpoint Inhibitor-Induced Liver Injury4
4
4
Bioengineered Liver Models for Investigating Disease Pathogenesis and Regenerative Medicine4
Understanding and Treating Hepatorenal Syndrome: Insights from Recent Research4
Alcohol-Metabolizing Enzymes, Liver Diseases and Cancer4
Gestational and Developmental Contributors of Pediatric MASLD4
4
Drug-Induced Vanishing Bile Duct Syndrome: From Pathogenesis to Diagnosis and Therapeutics4
The Ways to Die: Cell Death in Liver Pathophysiology4
Influence of Sex in the Development of Liver Diseases4
Mastering Core Recommendations during HEPAtology ROUNDS in Patients with Advanced Chronic Liver Disease3
Pathogenesis and Management of Intestinal Failure-Associated Liver Disease3
Preface (Introduction)3
Angiocrine Signaling in Sinusoidal Health and Disease3
Novel Antidiabetic Strategies and Diabetologists' Views in Nonalcoholic Steatohepatitis3
Role of Neutrophils in the Development of Steatotic Liver Disease3
Dietary Treatment for NAFLD: New Clinical and Epidemiological Evidence and Updated Recommendations3
3
3
Role of Hepatocyte Nuclear Factor 4 Alpha in Liver Cancer3
Treating Alcohol Use Disorder in Patients with Alcohol-Associated Liver Disease: Controversies in Pharmacological Therapy3
Novel Endoscopic Bariatric Therapies for the Management of Nonalcoholic Steatohepatitis3
Therapeutic Potential of Nutraceuticals against Drug-Induced Liver Injury3
The Ploidy State as a Determinant of Hepatocyte Proliferation3
0.091506004333496